Trial reportThe Lancet. Public health2022
Cost-effectiveness of a physical activity and behaviour maintenance programme on functional mobility decline in older adults: an economic evaluation of the REACT (Retirement in Action) trial.
Trial report in The Lancet. Public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 21 citations in OpenAlex.
- Application of the integrated rehabilitation-clinical-nutrition management model in geriatric rehabilitation patients: a narrative review.Frontiers in public health · 2026Pooled it
- Economic evidence related to the use of community assets in the management of frailty: a systematic review.Frontiers in public health · 2026Pooled it
- Pooled it
- Trial
- Neural Determinants of Sedentary Lifestyle in Older Adults: A Brain Network Analysis.Brain and behavior · 2025Trial
- A qualitative longitudinal study of motivation in the REtirement in ACTion (REACT) physical activity intervention for older adults with mobility limitations.The international journal of behavioral nutrition and physical activity · 2023Trial
- The REtirement in ACTion exercise programme and its effects on elements of long term functionality in older adults.Frontiers in public health · 2023Trial
- Effect of a physical activity and behaviour maintenance programme on functional mobility decline in older adults: the REACT (Retirement in Action) randomised controlled trial.The Lancet. Public health · 2022Trial
- Article
- Mitigating Stroke Risk in Type 2 Diabetes Through Physical Activity: A Nationwide Population-Based Study in Sweden.Journal of stroke · 2026Article
- Interaction between physical activity and deficit-based frailty on all-cause mortality in older adults: a prospective study of five population-based cohorts.The Lancet regional health. Western Pacific · 2026Article
- Exploring the cost-effectiveness and optimization strategies of nursing caring for children and older adults: a perspective.Frontiers in public health · 2026Article
- Togetherness in a Safe and Motivating Environment at Meeting Places: Older Persons' Experiences of Group Exercises.Journal of aging research · 2026Article
- Comparison of Elicit AI and Traditional Literature Searching in Evidence Syntheses Using Four Case Studies.Cochrane evidence synthesis and methods · 2025Article
- Associations between within-day step accumulation pattern and clinical measures of physical function: a change-for-change analysis of longitudinal data in community-dwelling older adults.The international journal of behavioral nutrition and physical activity · 2025Article
- Strategies for person-centredness at meeting places arranging group exercises for community-dwelling older persons- A focus group study from a stakeholder perspective.BMC public health · 2025Article
- Review
- Economic effects of healthy ageing: functional limitation, forgone wages, and medical and long-term care costs.Health economics review · 2023Article
- SnacktivityHealthcare (Basel, Switzerland) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 8 institutions in 2 countries.
Funding
Abstract
backgroundMobility limitations in older populations have a substantial impact on health outcomes, quality of life, and social care costs. The Retirement in Action (REACT) randomised controlled trial assessed a 12-month community-based group physical activity and behaviour maintenance intervention to help prevent decline in physical functioning in older adults at increased risk of mobility limitation. We aimed to do an economic evaluation of the REACT trial to investigate whether the intervention is cost-effective.
methodsIn this health economic evaluation, we did cost-effectiveness and cost-utility analyses of the REACT programme versus standard care on the basis of resource use, primary outcome, and health-related quality-of-life data measured in the REACT trial. We also developed a decision analytic Markov model that forecasts the mobility of recipients beyond the 24-month follow-up of the trial and translated this into future costs and potential benefit to health-related quality of life using the National Health Service and Personal Social Services perspective. Participants completed questionnaire booklets at baseline, and at 6, 12, and 24 months after randomisation, which included a resource use questionnaire and the EQ-5D-5L and 36-item short-form survey (SF-36) health-related quality-of-life instruments. The cost of delivering the intervention was estimated by identifying key resources, such as REACT session leader time, time of an individual to coordinate the programme, and venue hire. EQ-5D-5L and SF-36 responses were converted to preference-based utility values, which were used to estimate quality-adjusted life-years (QALYs) over the 24-month trial follow-up using the area-under-the-curve method. We used generalised linear models to examine the effect of the REACT programme on costs and QALYs and adjust for baseline covariates. Costs and QALYs beyond 12 months were discounted at 3·5% per year. This is a pre-planned analysis of the REACT trial; the trial itself is registered with ISRCTN (ISRCTN45627165).
findingsThe 12-month REACT programme was estimated to cost £622 per recipient to deliver. The most substantial cost components are the REACT session leader time (£309 per participant), venue hire (£109), and the REACT coordinator time (£80). The base-case analysis of the trial-based economic evaluation showed that reductions in health and social care usage due to the REACT programme could offset the REACT delivery costs (£3943 in the intervention group vs £4043 in the control group; difference: -£103 [95% CI -£695 to £489]) with a health benefit of 0·04 QALYs (0·009-0·071; 1·354 QALYs in the intervention group vs 1·314 QALYs in the control group) within the 24-month timeframe of the trial.
interpretationThe REACT programme could be considered a cost-effective approach for improving the health-related quality of life of older adults at risk of mobility limitations.
fundingNational Institute for Health Research Public Health Research Programme.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.